Lantheus Holdings, Inc. announced a strategic collaboration with Novartis to include PYLARIFY® in prostate cancer clinical trials with Pluvicto™.
[Lantheus Holdings, Inc.]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.